Search
for

    Glossary Quetiapine

    antipsychotic medication used to treat schizophrenia and bipolar disorder

    Quetiapine, also known by the brand name Seroquel, is an antipsychotic medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and major depressive disorder. It works by altering the actions of certain neurotransmitters in the brain, particularly serotonin and dopamine, to help stabilize mood and reduce symptoms like hallucinations and mood swings.

    Related Terms

    Research

    5 / 113 results
      Alopecia Associated with Quetiapine

      research Alopecia associated with quetiapine

      19 citations , February 2007 in “International Clinical Psychopharmacology”
      This study provided the first published case reports of alopecia associated with the use of quetiapine.

      research Quetiapine Induced Hair Loss in an Adolescent Case

      3 citations , February 2014 in “Anadolu psikiyatri dergisi”
      This report describes the first known case of alopecia in a 16-year-old patient associated with quetiapine use, which resolved after stopping the medication.
      Hair Loss as a Side Effect of Quetiapine: A Clinical Case Report

      research Hair Loss as a Side Effect of Quetiapine: A Clinical Case Report

      January 2025 in “Scholars Journal of Medical Case Reports”
      In this study, a 37-year-old Moroccan man experienced hair loss after two months of quetiapine treatment for major depressive disorder, which resolved after discontinuation, highlighting the need for awareness of this potential rare side effect.

      research Risk factors for intraoperative floppy iris syndrome: a retrospective study

      22 citations , June 2011 in “Acta Ophthalmologica”
      This study found that current use of benzodiazepines, α1-blockers (like tamsulosin, alfuzosin, terazosin), finasteride, and possibly rivastigmine is associated with increased risk of intraoperative floppy iris syndrome in cataract surgery patients.

      research Trichotillomania as a Manifestation of Dementia

      8 citations , January 2016 in “Case Reports in Psychiatry”
      The authors report a dementia patient who developed severe trichotillomania unresponsive to SSRIs, which improved with quetiapine; they suggest dopamine blockade may manage such symptoms in dementia.